Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -13.54% is 88% above its 5-year average of -114.78%, near the high end of its 5-year range (-591.90%–-2.67%).
As of the fiscal period ended Wednesday, December 31, 2025. 66.82% above its 12-month average of -40.81%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-13.54%
RETURN ON EQUITY (ROE) AVG TTM
-40.81%
RETURN ON EQUITY (ROE) AVG 3Y
-170.75%
RETURN ON EQUITY (ROE) AVG 5Y
-114.78%
RETURN ON EQUITY (ROE) AVG 10Y
-71.98%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+66.82%
CURRENT VS 3Y AVG
+92.07%
CURRENT VS 5Y AVG
+88.20%
CURRENT VS 10Y AVG
+81.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.65%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-216.22%
vs the sector median at left
Teladoc Health, Inc.
Market Cap
$1.29B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$453.52M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$412.54M
Return on Equity (ROE)
-28.18%
TTM Avg
-52.50%
3Y Avg
-47.15%
5Y Avg
-47.15%
Market Cap
$2.44B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$15.31M
Return on Equity (ROE)
-721.75%
TTM Avg
348.35%
3Y Avg
157.32%
5Y Avg
61.09%
Market Cap
$2.79B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$6.94B
Return on Equity (ROE)
-2.97%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$7.11B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$8.84B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.29B | -13.54% | -40.81% | -170.75% | -114.78% |
| NRC Health (NRC)vs › | $453.52M | 89.43% | 81.07% | 67.39% | 61.90% |
| Shoulder Innovations, Inc. (SI)vs › | $412.54M | -28.18% | -52.50% | -47.15% | -47.15% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.44B | -40.41% | -45.75% | -30.11% | -18.95% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -721.75% | 348.35% | 157.32% | 61.09% |
| TransMedics Group, Inc. (TMDX)vs › | $2.79B | 29.28% | 27.86% | 4.54% | -12.45% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.94B | -2.97% | 25.09% | 5.57% | 0.40% |
| Oscar Health, Inc. (OSCR)vs › | $7.11B | 26.84% | -21.41% | -36.14% | -25.75% |
| Tempus AI, Inc. (TEM)vs › | $8.84B | -57.18% | -651.33% | -315.37% | -198.08% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.35B | 3.10% | -8.94% | -15.72% | 1.14% |
ROE
-13.5%
ROA
-6.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -14.46% |
| 2024-12-31 | -67.15% |
| 2023-12-31 | -9.47% |
| 2022-12-31 | -591.90% |
| 2021-12-31 | -2.67% |
| 2020-12-31 | -3.05% |
| 2019-12-31 | -9.75% |
| 2018-12-31 | -9.58% |
| 2017-12-31 | -19.11% |
| 2016-12-31 | -32.15% |
| 2015-12-31 | -32.49% |
| 2014-12-31 | -32.01% |
| 2013-12-31 | -31.59% |
